Skip to main content
Intended for healthcare professionals

The mission of Substance Use & Addiction Journal (SAj) is to advance science through dissemination of high-quality, innovative research, and commentary related to substance use and substance use disorders by and for a broad range of stakeholders including clinicians, researchers, educators, policy makers, persons and advocates of persons who use substances, and public health and healthcare staff and leaders worldwide. (SAj) is committed to improving health, health care, and health equity for vulnerable populations. View full journal description

Browse by

Articles most recently published online for this journal.
Restricted access
Research article
First published  

Influence of Attitudes on Recovery Residence Acceptance and Use of Medication for Opioid Use Disorder

  • Cynthia Nichols PhD, MSW
Open Access
Research article
First published  

Behavioural Intentions Associated with Exposure to Anabolic-Androgenic Steroid Testing Results: A Two-Phase, Multi-Wave Intervention Trial

  • Timothy Piatkowski PhD
  • Ross Coomber PhD
  • Cameron Francis BSW
  • Emma Kill MSW
  • Geoff Davey MBA
  • Sarah Cresswell PhD
  • Alan White MSc
  • Madeline Harding BSc(Hons)
  • Karen Blakey MSc
  • Steph Reeve BSc(Hons)
  • Brooke Walters MSW
  • Cheneal Puljević PhD
  • Jason Ferris PhD
  • Benjamin Bonenti BSc(Hons)
  • Luke T. J. Cox PhD
  • Monica J. Barratt PhD
Restricted access
Brief report
First published  

Association Between Medication for Alcohol Use Disorder and Confirmed Linkage to Care Following Discharge From an Inpatient Unit for Medically Managed Withdrawal

  • John C. Messinger MD
  • Lisa Vercollone MD, PharmD
  • Sara Prostko
  • Samuel Maddams
  • Jeremiah Tom MD
  • Bijan Zarrabi MD
  • Jad Hilal MD
  • Veronica Szpak
  • David Hathaway MD
  • Peter Chai MD, MS
  • Joji Suzuki MD
Open Access
Brief report
First published  

Investigating the Legitimacy of Anabolic-Androgenic Steroids in Australia’s Unregulated Market Using Community Testing Data

  • Benjamin Bonenti BPsych (Hons I)
  • Alison Craven BSc(Hons)
  • Jason Ferris PhD
  • Connor Walsh
  • Merryn Armstrong BSc
  • Timothy Piatkowski PhD
View onlinefirst articles View latest issues
Most read articles in this journal in the last 6 months.
Open Access
Review article
First published  

Naloxone Distribution Models in the United States: A Scoping Review

  • Nina Vadiei PharmD, BCPP
  • David R. Axon PhD, MPharm, MS, MRPharmS
  • Becka Eckert BSN, RN
Available access
Research article
First published  

A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States

  • Marina Gaeta Gazzola MD
  • Iain D. Carmichael PhD
  • Nicholaus J. Christian MD, MBA
  • Xiaoying Zheng BS
  • Lynn M. Madden PhD
  • Declan T. Barry PhD
Open Access
Case report
First published  

Outpatient Initiation of 7-Day Injectable Buprenorphine: A Direct-to-Inject Case Series

  • Sarah Rosenwohl-Mack MD
  • Leslie W. Suen MD
  • Alexander A. Logan MD
  • Damian Peterson PharmD
  • Hannah R. Snyder MD
Open Access
Case report
First published  

Long-Term Buprenorphine Treatment for Kratom use Disorder: A Case Series

  • Viktoriya R. Broyan MS
  • Jessica K. Brar BS
  • Tristen Allgaier
  • Jeffrey T. Allgaier MD, FACEP, FASAM
View all
Most cited articles published in this journal in the last 3 years. These statistics are updated weekly using data sourced exclusively from CrossRef.
Restricted access
Review article
First published  

Effects of Smoking Marijuana on the Respiratory System: A Systematic Review

  • Jorge Vásconez-González MSc
  • Karen Delgado-Moreira MD
  • Belén López-Molina MD
  • Juan S. Izquierdo-Condoy MSc
  • Esteban Gámez-Rivera MD
  • Esteban Ortiz-Prado PhD
Restricted access
Research article
First published  

Xylazine-Associated Wounds and Related Health Concerns Among People Who Use Drugs: Reports From Front-Line Health Workers in 7 US States

  • Jennifer J. Carroll PhD, MPH
Restricted access
Article commentary
First published  

Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act

  • Brendan Saloner PhD
  • Barbara Andraka-Christou JD, PhD
  • Bradley D. Stein MD, PhD
  • Adam J. Gordon MD
Restricted access
Research article
First published  

Rapid Methadone Induction in a General Hospital Setting: A Retrospective, Observational Analysis

  • Sarah Casey BA
  • Susan Regan PhD
  • Evan Gale MD
  • Zoe M. Adams MD, MA
  • Eugene Lambert MD, MBA
  • Faith O. Omede MD
  • Sarah E. Wakeman MD
View all
Articles with the highest Altmetric score from the last 3 months, indicating influence and impact.
AMERSA Position Statements
Editors' Choice
National Recovery Month Highlights
Youth & Substance Use
Policy Impact
How to respond to reviewer comments
How to get more involved with a journal & develop your career
How to perform a literature review
How to write and structure an article’s front matter

You might be interested in

Blog

Check out our blog to read a recap of the latest research published in SAj.
Read More

Publish with us

Authors will enjoy:

  • Rigorous peer review of your research
  • Prompt publishing
  • Multidisciplinary audience
  • High visibility for global exposure
Submit Now

Reviewer rewards

Explore the rewards available to you for completing a review for SAj, including discounts, credit, and more.

Read More

Information for Authors, Editors, and Reviewers

Sage supports authors, editors, and reviewers throughout all steps of the publishing process. Explore our resources:

SAj Editors' Choice Collection

Read recent Editor's Choice articles on timely and important research.
Read More

AMERSA Educational Resources

AMERSA offers a variety of evidence-based educational programs for a multidisciplinary audience, including the annual conference - explore current offerings below.

Also from Sage